News of Note—Sanofi, ImmusanT and more

Here is some other vaccine news of note for the week:

> Dyadic will collaborate with Sanofi to explore how its C1 gene expression platform can be applied to Sanofi's vaccine and biologic offerings. The platform aims to speed development and reduce production costs for biologics. Release

> ImmusanT picked up funding from JDRF to work on a Type 1 diabetes vaccine. FierceBiotech article

> A drug combo containing a cancer vaccine showed promise against melanoma in a preclinical study. Release